Skip to main content

Table 2 Characteristics of patients with Clostridioides difficile infection (CDI) due to the ribotype 027 strain (Cases) versus CDI due to non-027 strains (Controls)

From: Risk factors for Clostridioides difficile infection caused by ribotype 027 strains in the Veterans Affairs Healthcare System: a matched case-control study

Characteristics

Cases (n=3,353)

Controls

(n=10,059)

OR (95% CI)

Univariate Analysis P Value

Gender male (%)

3191 (95.2)

9412 (93.6)

1.35 (1.14–1.61)

0.001

Age >65 years old (%)

2413 (72.0)

6308 (62.7)

1.53 (1.41–1.66)

<0.001

BMI, kg/m2 [Mean (SD)]

27.27 (7.61)

27.76 (7.39)

0.99 (0.98–0.99)

0.001

Race, White (%)

2760 (82.3)

8204 (81.6)

1.06 (0.95–1.17)

0.300

CCIS [Mean (SD)]

4.27 (3.26)

3.91 (3.25)

1.04 (1.02–1.04)

0.001

Braden Scale (%)

 No Risk

1617 (48.2)

5806 (57.7)

Ref

 

 Mild

1257 (37.5)

3211 (31.9)

1.43 (1.31–1.56)

0.000

 Moderate

273 (8.1)

619 (6.2)

1.62 (1.39–1.89)

0.000

 High

206 (6.1)

423 (4.2)

1.79 (1.5–2.14)

0.000

Inflammatory Bowel Disease (%)

56 (1.7)

389 (3.9)

0.42 (0.31–0.56)

<0.001

Diabetes Mellitus (%)

1456 (43.4)

4019 (40.0)

1.16 (1.07–1.25)

0.000

Cancer (%)

903 (26.9)

2622 (26.1)

1.05 (0.96–1.14)

0.323

Cirrhosis (%)

234 (7.0)

648 (6.4)

1.09 (0.93–1.27)

0.276

Gastrointestinal procedure (%)

67 (2.0)

230 (2.3)

0.87 (0.66–1.15)

0.327

Nasal colonization MRSA (%)

528 (15.7)

1038 (10.3)

1.66 (1.48–1.86)

<0.001

Serum creatinine, >1.3 mg/dL (%)

1484 (44.3)

4019 (40.0)

1.2 (1.1–1.29)

<0.001

Peripheral WBC count, ≥11,000/mm (%)

1641 (48.9)

3618 (36.0)

1.71 (1.58–1.85)

<0.001

Serum albumin, <3.5 g/dL (%)

2496 (74.4)

6435 (64.0)

1.69 (1.55–1.86)

<0.001

PPIs (%)

1911 (57.0)

5783 (57.5)

0.98 (0.9–1.06)

0.610

H2RAs (%)

598 (17.8)

1709 (17.0)

1.06 (0.96–1.18)

0.257

High-risk antibiotic time of exposure within 90 days (%)

 None

1137 (33.9)

4502 (44.8)

  

 ≤5 days

872 (26.0)

2511 (25.0)

1.39 (1.25–1.54)

<0.001

 6–14 days

962 (28.7)

2222 (22.1)

1.75 (1.58–1.93)

<0.001

 ≥14 days

382 (11.4)

824 (8.2)

1.90 (1.65–2.18)

<0.001

Epidemiological Classification

 Community-associated

1001 (29.9)

4016 (39.9)

Ref

 

 Healthcare-associated

2182 (65.1)

5458 (54.3)

1.64 (1.5–1.79)

<0.001

 Undetermined

170 (5.1)

585 (5.8)

1.14 (0.94–1.38)

0.195

  1. Data are no. (%) of patients, unless otherwise specified
  2. Abbreviations: OR odds ratio, CCIS Charlson Comorbidity Index Score, BMI body mass index, MRSA methicillin-resistant Staphylococcus aureus, WBC White blood cells, PPI Proton pump inhibitors, H2RAs Histamine H2-receptor antagonists